- About Synapse
- How to Participate
- KAMJE Databases
- About Synapse
- How to Participate
- KAMJE Databases
- Home
- Journal List
- Cancer Res Treat
29 results
| 695 |
Up and Down of Cancer Research and Treatment (CRT)’s Journal Impact Factor at the Moment of CRT’s 60th Anniversary
Yong Chan Ahn
KMSID: 1516096526 Cancer Res Treat. 2026;58(3):695-696. Published online 2026 June 23 DOI: http://dx.doi.org/10.4143/crt.2026.0664   | |
| 697 |
Toward Sustainable Care in HER2-Positive Metastatic Breast Cancer: Emerging Evidence for Treatment De-escalation
Matilda Xinwei Lee, Soo Chin Lee
KMSID: 1516096503 Cancer Res Treat. 2026;58(3):697-708. Published online 2026 April 23 DOI: http://dx.doi.org/10.4143/crt.2025.1131 | |
| 709 |
Characteristics of Immune Checkpoint Inhibitor–Related Hepatotoxicity Based on the Baseline Liver Function
Won-Jung Jung, Eun-Jung Jo, Ye-Jee Kim, Mihyun Park, Eunji Kim, Yu-Seon Jung, Sook Ryun Park, Ji Seon Oh, So-Hui Kim, Jeongbin Park, Sun-Young Jung, Nakyung Jeon
KMSID: 1516096502 Cancer Res Treat. 2026;58(3):709-719. Published online 2025 July 18 DOI: http://dx.doi.org/10.4143/crt.2025.040  | |
| 720 |
Barriers to Clinical Trial Enrollment: KCSG Survey–Based Perspectives of Medical Oncologists, Patients, and Their Caregivers
Chi Hoon Maeng, Inkeun Park, In Hee Lee, Ho Jung An, Hyun Jeong Shim, Sang-Cheol Lee
KMSID: 1516096518 Cancer Res Treat. 2026;58(3):720-727. Published online 2025 July 7 DOI: http://dx.doi.org/10.4143/crt.2025.523 | |
| 728 |
Risk Stratification in T4 or N3 Nasopharyngeal Carcinoma
Lin-Feng Guo, Lu-Chao Zhu, Yi-Feng Yu, Zhen-Zhen Lu, Qin Lin, San-Gang Wu
KMSID: 1516096520 Cancer Res Treat. 2026;58(3):728-737. Published online 2025 August 12 DOI: http://dx.doi.org/10.4143/crt.2025.573 | |
| 738 |
Genomic Insights into Innate Resistance in Early-Stage EGFR-Mutant Non–Small Cell Lung Cancer: A Comprehensive Analysis of Next-Generation Sequencing Data
Hayoung Seong, Soo Han Kim, Mi-Hyun Kim, Ahrong Kim, Ju Sun Song, Jung Seop Eom
KMSID: 1516096504 Cancer Res Treat. 2026;58(3):738-747. Published online 2025 August 25 DOI: http://dx.doi.org/10.4143/crt.2025.114 | |
| 748 |
Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer
Yeonjin Jeon, GunHee Lee, Byung-Kwan Jeong, Yoon Young Kim, JiSun Kim, Jae Ho Jeong, Kyunggon Kim, Hee Jin Lee
KMSID: 1516096506 Cancer Res Treat. 2026;58(3):748-769. Published online 2025 July 28 DOI: http://dx.doi.org/10.4143/crt.2025.145 | |
| 770 |
HER3 Expression and PIK3CA Mutational Status Predict Pathological Response of Neoadjuvant Therapy in HER2-Positive Breast Cancer Patients
Xi Xia, Zhiqiang Zong, Jian Shen, Lingling Zhou, Yang Lei, Jia Li, Lu Zheng, Fanfan Li, Hua Wang
KMSID: 1516096508 Cancer Res Treat. 2026;58(3):770-779. Published online 2025 July 2 DOI: http://dx.doi.org/10.4143/crt.2025.242 | |
| 780 |
Impact of High Lymph Node Burden on Brain Metastases in Patients Who Achieved Pathological Complete Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Seung Ah Lee, Ki Jo Kim, Do Youn Woen, Su Min Lee, Kawon Oh, Cho Eun Lee, Woong Ki Park, Ji Won Yoo, Dong Seung Shin, Jai Min Ryu, Se Kyung Lee, Byung Joo Chae, Jonghan Yu, Seok Won Kim, Seok Jin Nam, Ji-Yeon Kim, Yeon Hee Park, Eun Young Ko, Eun Sook Ko, Jeong Eon Lee
KMSID: 1516096507 Cancer Res Treat. 2026;58(3):780-789. Published online 2025 July 8 DOI: http://dx.doi.org/10.4143/crt.2025.219 | |
| 790 |
Keratin 6A Overexpression in the Lymphovascular Invasion–Associated Tumor Subgroup Promotes Progression of Triple-Negative Breast Cancer
Wei Luo, Yiping Zou, Yantao Jiang, Xi Ma, Shuyue Guo, Yao Wang, Yuxiao Liu, Linyue Hai, Wenbin Jia, Wenbo Liu, Ran Meng, Xuchen Cao, Xianhui Ruan, Yue Yu
KMSID: 1516096511 Cancer Res Treat. 2026;58(3):790-814. Published online 2025 July 14 DOI: http://dx.doi.org/10.4143/crt.2025.423 | |
| 815 |
Nomograms Integrating Body Composition Metrics Predict Total Pathologic Complete Response after Neoadjuvant Systemic Therapy for Breast Cancer
Jingjing Ding, Yichun Gong, Jue Wang, Yuanyuan Wang, Hao Yao, Xingye Sheng, Mingyu Wang, Danni Shen, Junhan Li, Xiaoming Zha, Lu Xu
KMSID: 1516096513 Cancer Res Treat. 2026;58(3):815-823. Published online 2025 August 18 DOI: http://dx.doi.org/10.4143/crt.2025.456 | |
| 824 |
Microbial Dynamics across Molecular Subtypes and Prognostic Significance of Lactobacillus in Gastric Cancer
Soo Kyung Nam, Juhyeong Park, Sujin Oh, Yoonjin Kwak, Cheol Min Shin, Kyoung Un Park, Nak-Jung Kwon, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Han-Kwang Yang, Hye Seung Lee
KMSID: 1516096514 Cancer Res Treat. 2026;58(3):824-845. Published online 2025 July 17 DOI: http://dx.doi.org/10.4143/crt.2025.449 | |
| 846 |
Nivolumab Plus Chemotherapy versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)
Yoon-Koo Kang, Min-Hee Ryu, Do-Youn Oh, Sang Cheul Oh, Sun Young Rha, Keun-Wook Lee, Ik Joo Chung, Sung Yong Oh, Sun Jin Sym, Won Ki Kang, Jong Gwang Kim, Byoung Yong Shim, In-Ho Kim, Jin Young Kim, Eun-Kee Song, Hyo-Jin Lee, Seok Yun Kang, Dong-Hoe Koo, So Yeon Oh
KMSID: 1516096501 Cancer Res Treat. 2026;58(3):846-859. Published online 2025 July 2 DOI: http://dx.doi.org/10.4143/crt.2024.913 | |
| 860 |
Clinicopathological Factors Influencing PD-L1 Expression and the Effect of Immune Checkpoint Inhibitors on Survival Outcomes in Patients with Gastric Cancer Depending on Sex in a Tertiary Hospital in South Korea
Jeong Hwan Lee, Nayoung Kim, Ji-Hyun Kim, Hyeon Jeong Oh, Yeejin Kim, Yonghoon Choi, Hyemin Jo, Ho-Kyoung Lee, Jinju Choi, Yu Kyung Jun, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hye Seung Lee, So Hyun Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn
KMSID: 1516096505 Cancer Res Treat. 2026;58(3):860-871. Published online 2025 August 13 DOI: http://dx.doi.org/10.4143/crt.2025.126 | |
| 872 |
Korean Colorectal Cancer Screening Guidelines for Asymptomatic, Average-Risk Adults: The 2025 Revision
EunKyo Kang, Jae Myung Cha, Seo Young Kang, Kiheon Lee, Su Young Kim, Younghoon Kim, An Na Seo, Hyo-Jin Kang, Jong Keon Jang, Kwang-Pil Ko, Aesun Shin, Dae Kyung Sohn, Youngki Hong, Eun-Jung Cho, Minje Han, Soo Young Kim, Hyeon Ji Lee, Chang Kyun Choi, Mina Suh
KMSID: 1516096527 Cancer Res Treat. 2026;58(3):872-883. Published online 2026 March 13 DOI: http://dx.doi.org/10.4143/crt.2026.014 | |
| 884 |
Effectiveness of Radiotherapy for Hepatocellular Carcinoma with Lymph Node Metastasis: A Meta-Analysis
Sooyoung Hwang, Seoon Hur, Won Sup Yoon, Sunmin Park, Chai Hong Rim
KMSID: 1516096515 Cancer Res Treat. 2026;58(3):884-896. Published online 2025 August 12 DOI: http://dx.doi.org/10.4143/crt.2025.475 | |
| 897 |
Efficacy and Safety of Lenvatinib Plus Everolimus in Metastatic Renal Cell Carcinoma after Immune Checkpoint and VEGFR Tyrosine Kinase Inhibitors Treatment
So Heun Lee, Inkeun Park, Shinkyo Yoon, Jae Lyun Lee
KMSID: 1516096522 Cancer Res Treat. 2026;58(3):897-905. Published online 2025 August 13 DOI: http://dx.doi.org/10.4143/crt.2025.628 | |
| 906 |
Combination of Niraparib and Lapatinib for Ovarian Cancer Treatment
Feiyun Jiang, Xingyu Liu, Yalan Wei, Yeping Ding, Wen Cai, Shanshan Xu, Bin Tang
KMSID: 1516096519 Cancer Res Treat. 2026;58(3):906-922. Published online 2025 July 29 DOI: http://dx.doi.org/10.4143/crt.2025.553 | |
| 923 |
Pancreatic Irradiation Dose as a Risk Factor for Elevation in Hemoglobin A1c Level and Diabetes Mellitus in Patients with Indolent Gastroduodenal Lymphoma
Jong Yun Baek, Do Hoon Lim, Dongryul Oh, Jae J Kim, Jun Haeng Lee, Byung-Hoon Min, Hyuk Lee
KMSID: 1516096521 Cancer Res Treat. 2026;58(3):923-930. Published online 2025 July 29 DOI: http://dx.doi.org/10.4143/crt.2025.585 | |
| 931 |
Clinicopathological Significance of Tumor-Infiltrating T Lymphocytes and Macrophages in Primary Large B-Cell Lymphoma of Immune-Privileged Sites
Jinseong Kim, Deokhoon Kim, Hyungwoo Cho, Dok Hyun Yoon, Heounjeong Go
KMSID: 1516096523 Cancer Res Treat. 2026;58(3):931-944. Published online 2025 August 13 DOI: http://dx.doi.org/10.4143/crt.2025.641 | |
| 945 |
Comparative Effectiveness of Anbalcabtagene Autoleucel versus Tisagenlecleucel in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hee-Jin Seo, Woo Hyeon Yoo, Kyungyeon Jung, Ji Won Kim, Ju-Young Shin, Ju Hwan Kim, Won Seog Kim
KMSID: 1516096509 Cancer Res Treat. 2026;58(3):945-953. Published online 2025 July 11 DOI: http://dx.doi.org/10.4143/crt.2025.276 | |
| 954 |
Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera
Ji Yun Lee, Sung-Soo Yoon, Deok-Hwan Yang, Sang Kyun Sohn, Seug Yun Yoon, Soo-Mee Bang, Gyeong-Won Lee, Chul Won Choi, Eun-Ji Choi, June-Won Cheong, Young Hoon Park, Sung-Eun Lee
KMSID: 1516096517 Cancer Res Treat. 2026;58(3):954-962. Published online 2025 June 26 DOI: http://dx.doi.org/10.4143/crt.2025.552 | |
| 963 |
A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906)
Kwai Han Yoo, Sang Eun Yoon, Ka-Won Kang, Jun Ho Yi, Min Kyoung Kim, Hyo Jung Kim, Sung-Hyun Kim, Joon Seong Park, Sung-Hoon Jung, Je-Jung Lee, Chang-Ki Min, Jae Hoon Lee, Duck Cho, Kihyun Kim
KMSID: 1516096512 Cancer Res Treat. 2026;58(3):963-970. Published online 2025 June 30 DOI: http://dx.doi.org/10.4143/crt.2025.426 | |
| 971 |
Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in Korea
Jun Ho Yi, Jae Hoon Lee, Sung‑Hoon Jung, Ji Hyun Lee, Ji Yun Lee, Kihyun Kim, Sung‑Soo Park, Chang‑Ki Min, Yoon Seok Choi, Min Kyoung Kim, Ho-Young Yhim, Dok Hyun Yoon
KMSID: 1516096510 Cancer Res Treat. 2026;58(3):971-978. Published online 2025 July 30 DOI: http://dx.doi.org/10.4143/crt.2025.399 | |
| 979 |
A Novel CD58 Mutation–Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients
Hui-Li Wang, Chun-Yu Shang, Wei Hua, Hua Yin, Yue Li, Jun-Heng Liang, Rui Gao, Bi-Hui Pan, Xin-Yu Zhang, Jia-Zhu Wu, Hao-Rui Shen, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
KMSID: 1516096500 Cancer Res Treat. 2026;58(3):979-1001. Published online 2025 July 28 DOI: http://dx.doi.org/10.4143/crt.2024.1143 | |
| 1002 |
BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma
Chun-Yu Shang, Wei Hua, Tong-Yao Xing, Kai-Xin Du, Yi-fan Wu, Yue Li, Hua Yin, Hao-Rui Shen, Li Wang, Jian-Yong Li, Rui Gao, Wei Xu, Jin-Hua Liang
KMSID: 1516096516 Cancer Res Treat. 2026;58(3):1002-1020. Published online 2025 July 30 DOI: http://dx.doi.org/10.4143/crt.2025.494 | |
| 1021 |
Commentary on “Skeletal Muscle Index to Red Cell Distribution Width Ratio: A Novel Prognostic Indicator for Patients with Stage I-III Colorectal Cancer”
Yiheng Yu, Daxiong Zeng
KMSID: 1516096524 Cancer Res Treat. 2026;58(3):1021-1021. Published online 2026 May 20 DOI: http://dx.doi.org/10.4143/crt.2026.0056 | |
| 1022 |
Commentary on “Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: a European and East Asian Populations-Based Mendelian Randomization Analysis”
Fei Ying, Xuan Zhao, Tao Wang
KMSID: 1516096525 Cancer Res Treat. 2026;58(3):1022-1023. Published online 2026 June 22 DOI: http://dx.doi.org/10.4143/crt.2026.0076 | |
| 1024 |
RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
KMSID: 1516096499 Cancer Res Treat. 2026;58(3):1024-1024. Published online 2026 June 19 DOI: http://dx.doi.org/10.4143/crt.2017.085.RE | |